| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $131.7M | +0.4% | +13.1% |
| Cost of Revenue | $29.6M | +3.3% | +49.0% |
| Gross Profit | $102.1M | -0.5% | +5.7% |
| R&D Expense | $25.2M | -4.4% | +9.5% |
| SG&A Expense | $24.3M | +4.6% | +40.2% |
| Operating Income | $11.6M | +14.6% | -51.5% |
| Pre-tax Income | $7.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $101.4M | +8.1% | -41.9% |
| Accounts Receivable | $44.9M | -5.4% | +13.4% |
| Current Assets | $200.3M | +7.3% | -29.0% |
| Total Assets | $1.40B | +0.9% | +14.3% |
| Current Liabilities | $158.4M | +4.8% | +68.9% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $67.9M | — | — |
| Capital Expenditures | $13.7M | — | — |
| Investing Cash Flow | -$22.0M | — | — |
| Financing Cash Flow | -$37.1M | — | — |
| Free Cash Flow | $54.2M | — | — |
| +558.9% |
| -58.4% |
| Income Tax | $6.4M | +22.7% | -19.1% |
| Net Income | $1.4M | +134.4% | -87.1% |
| EPS (Basic) | $0.01 | +150.0% | -83.3% |
| EPS (Diluted) | $0.01 | +150.0% | -83.3% |
| $331.7M |
| -0.1% |
| -0.6% |
| Total Liabilities | $584.7M | +1.4% | +27.5% |
| Stockholders' Equity | $813.4M | +0.5% | +6.3% |